United States District Court, D. Maryland
WILLIAM D. QUARLES, Jr., District Judge.
Before the Court is Christopher Mills' request for emergency injunctive relief and the Response filed by the Office of the Attorney General. (ECF 1, 7). On April 13, 2015, the Court informed Mr. Mills that counsel's response will be construed as a Motion for Summary Judgment, and granted him an opportunity to reply consonant with the holding in Roseboro v. Garrison .  (ECF 8, 9). Also pending are Mr. Mills' Motion for Judgment of Damages and two Motions to Stay this case. (ECF 10, 11, 13).
The matter is ripe for review and a hearing is not necessary. See Local Rule 105.6 (D. Md. 2014). For the reasons stated herein, summary judgment will be granted in favor of Defendants and counsel shall file a status report within thirty days indicating the date Mr. Mills' medical treatment will commence.
On March 4, 2015, Mr. Mills, who is an inmate at North Branch Correctional Institution in Cumberland, Maryland, filed a Complaint claiming denial of adequate medical treatment for Hepatitis C and requesting injunctive relief. Specifically, he requested that he be prescribed the medication Harvoni to treat Hepatitis C. (ECF 1). He explained that he has portal hypertension and an enlarged spleen due to extensive scaring of the liver due to cirrhosis. Treatment of this condition with the medication Interferon was stopped due to his low platelet count. Id. Mr. Mills, who states he is "Interferon resistant, " (ECF 1, p. 3), has also submitted an article from Healthline News which identifies Harvoni as a medication used to treat Hepatitis C that does not require use of Interferon. (ECF 1-1 p. 2). Mr. Mills asserts he is "experiencing continued daily pain and if the defendants do not provide [him] with the drug (Harvoni) [his] liver will become decompensated cirrhosis [sic] which is irreversible." (ECF 1-2. p. 1).
On April 9, 2015, the Office of the Attorney General, by its attorneys, responded with verified exhibits and declarations. (ECF 7). Counsel explained that antiviral therapy treatment protocol for Hepatitis C ("HCV") involves evaluation by a Department of Public Safety and Correctional Services' (DPSCS) HCV Panel comprised of Wexford regional medical directors and site specific providers, medical and mental health physicians for Wexford, MHM (the mental health provider), the statewide epidemiologist for Wexford, the statewide clinical pharmacologist for Correct RX (the pharmacy vendor), and the Wexford contracted statewide infectious disease specialist. (ECF 7-1, pp. 2-3, 9-14). Inmates requesting treatment with new HCV medications can be referred directly to the Wexford infectious disease consultant for consideration prior to panel assessment, but in order to receive the medications the panel process must be completed. Id. at 8.
The Response indicates that on March 30, 2015, Mr. Mills was approved by the Hepatitis C Clinical Review Panel for administration of Harvoni, and will be given the medication for six months or twenty-four weeks. (ECF 7, p. 8, see also ECF 7-2, ECF 7-3). Id. In light of this approval, counsel argues Mr. Mills' request for injunctive relief is moot. Further, counsel asserts Mr. Mills fails to satisfy the standard for issuance of preliminary injunctive relief required by Winter v. Natural Resources Defense Council, Inc., 555 U.S. 7, 20 (2008).
A. Motion for Summary Judgment
Plaintiff was notified Defendants' substantive response will be treated as motion for summary judgment under Fed.R.Civ.P. 56. A motion styled in this manner implicates the court's discretion under Rule 12(d) of the Federal Rules of Civil Procedure. See Kensington Vol. Fire Dept., Inc. v. Montgomery County, 788 F.Supp.2d 431, 436-37 (D. Md. 2011). Ordinarily, a court "is not to consider matters outside the pleadings or resolve factual disputes when ruling on a motion to dismiss." Bosiger, 510 F.3d at 450. However, under Rule 12(b)(6), a court, in its discretion, may consider matters outside of the pleadings, pursuant to Rule 12(d). If the court does so, "the motion must be treated as one for summary judgment under Rule 56, " and "[a]ll parties must be given a reasonable opportunity to present all the material that is pertinent to the motion." Fed.R.Civ.P. 12(d).
Rule 56 of the Federal Rules of Civil Procedure provides that a court "shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law." Fed.R.Civ.P. 56(c). A material fact is one that "might affect the outcome of the suit under the governing law." Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986). A genuine issue over a material fact exists "if the evidence is such that a reasonable jury could return a verdict for the nonmoving party." Id. In considering a motion for summary judgment, a judge's function is limited to determining whether sufficient evidence exists on a claimed factual dispute to warrant submission of the matter to a jury for resolution at trial. Id. at 249.
In undertaking this inquiry, the Court must consider the facts and all reasonable inferences in the light most favorable to the nonmoving party. Ricci v. DeStefano, 129 S.Ct. 2658, 2677 (U.S. 2009); Scott v. Harris, 550 U.S. 372, 378 (2007). The Court must also abide by its affirmative obligation to prevent factually unsupported claims and defenses from going to trial. Drewitt v. Pratt, 999 F.2d 774, 778-79 (4th Cir. 1993). If the evidence presented by the nonmoving party is merely colorable, or is not significantly probative, summary judgment must be granted. Anderson, 477 U.S. at 249-50. On the other hand, a party opposing summary judgment must "do more than simply show that there is some metaphysical doubt as to the material facts." Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 586 (1986); see also In re Apex Express Corp., 190 F.3d 624, 633 (4th Cir. 1999). This Court has previously explained that a "party cannot create a genuine dispute of material fact through mere speculation or compilation of inferences." Shin v. Shalala, 166 F.Supp.2d 373, 375 (D. Md. 2001) (citations omitted).
Under these circumstances, the Court finds that even when the facts and all reasonable inferences are considered in the light most favorable to Mr. Mills, no genuine issue of material fact is presented, and judgment in favor of Defendants is appropriate. Mills does not dispute he has been approved for Harvoni treatment, the relief he seeks in his request for injunctive relief. To the extent he expresses concern about when treatment will commence (ECF 13), the Court will direct counsel to file a status report within thirty days stating ...